XON-27

N/A

Report date: 2024/07/12 09:36:03

First In Class

Base Information

Drug NameXON-27

Drug Alias NameXON-27

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies

Mechanisms of ActionAntibody-dependent cellular phagocytosis (ADCP) effectsComplement dependent cytotoxicity (CDC) effectsApoptosis inducers

TargetsUpdating

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesXenothera Sas

China Registration ClassN/A

Active CompaniesXenothera Sas

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A